Catalyst
Slingshot members are tracking this event:
Topline Results in Phase 2 Clinical Trial of FMX-103 Minocycline Topical Foam for Moderate-to-Severe Papulopustular Rosacea
- Source Link:
- https://viavid.webcasts.com/starthere.jsp?ei=1116723
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| FOMX | Community voting in process | |||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 12, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 2, Fmx-103, Minocycline Topical Foam, Moderate-to-severe Papulopustular Rosacea
